Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
Salvatore D’Angelo,1 Giuseppina Tramontano,1 Michele Gilio,1 Pietro Leccese,1 Ignazio Olivieri1,2 1Rheumatology Institute of Lucania (IRel) - Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza and Matera, 2Basilicata Ricer...
Saved in:
| Main Authors: | D'Angelo S, Tramontano G, Gilio M, Leccese P, Olivieri I |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/2f583fd1e7ab4b059234f1b123310e4a |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
by: Fusun Gediz, et al.
Published: (2021) -
Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
by: Maria-Loukia Koutsompina, et al.
Published: (2021) -
Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series
by: Brown AN
Published: (2016) -
An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
by: Acosta-Felquer ML, et al.
Published: (2016) -
Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
by: Sueli Carneiro, et al.
Published: (2021)